These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 18836333)

  • 21. Renal cell carcinoma rates compared with health status and behavior in the United States.
    Colli JL; Busby JE; Amling CL
    Urology; 2009 Feb; 73(2):431-6. PubMed ID: 18701146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study.
    Van Dijk BA; Schouten LJ; Hulsbergen-van de Kaa CA; van Houwelingen KP; Schalken JA; Kiemeney LA; Geurts van Kessel AH; Bausch-Goldbohm RA; van den Brandt PA
    IARC Sci Publ; 2002; 156():509-10. PubMed ID: 12484247
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal cell carcinoma: etiology, incidence and epidemiology.
    Murai M; Oya M
    Curr Opin Urol; 2004 Jul; 14(4):229-33. PubMed ID: 15205579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnosis of renal cell cancer in relation to hypertension (United States).
    Rosenberg L; Stephenson WP; Rao RS; Palmer JR; Strom BL; Shapiro S
    Cancer Causes Control; 1998 Dec; 9(6):611-4. PubMed ID: 10189046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary renal tumors: More common than expected?].
    Agaimy A; Hartmann A
    Pathologe; 2016 Mar; 37(2):134-43. PubMed ID: 26979427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of Renal Cell Carcinoma: 2022 Update.
    Bukavina L; Bensalah K; Bray F; Carlo M; Challacombe B; Karam JA; Kassouf W; Mitchell T; Montironi R; O'Brien T; Panebianco V; Scelo G; Shuch B; van Poppel H; Blosser CD; Psutka SP
    Eur Urol; 2022 Nov; 82(5):529-542. PubMed ID: 36100483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors for renal carcinoma in older women].
    Appel K; Rohde D
    Aktuelle Urol; 2004 Sep; 35(5):357-9. PubMed ID: 15383995
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for adult renal cell carcinoma.
    Dhote R; Thiounn N; Debré B; Vidal-Trecan G
    Urol Clin North Am; 2004 May; 31(2):237-47. PubMed ID: 15123404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
    Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
    J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
    Liu H; Sundquist J; Hemminki K
    Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.
    Smits KM; Schouten LJ; Hudak E; Verhage B; van Dijk BA; Hulsbergen-van de Kaa CA; Goldbohm RA; Oosterwijk E; van den Brandt PA
    Ann Epidemiol; 2010 May; 20(5):401-4. PubMed ID: 20382342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of tumors of the renal parenchyma].
    Robles JE; Rosell D; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 1999; 43(2):68-76. PubMed ID: 11256006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition.
    Tahbaz R; Schmid M; Merseburger AS
    Curr Opin Urol; 2018 Jan; 28(1):62-79. PubMed ID: 29059103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population attributable risk of renal cell cancer in Minnesota.
    Benichou J; Chow WH; McLaughlin JK; Mandel JS; Fraumeni JF
    Am J Epidemiol; 1998 Sep; 148(5):424-30. PubMed ID: 9737554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.
    Maher ER; Yates JR; Ferguson-Smith MA
    J Med Genet; 1990 May; 27(5):311-4. PubMed ID: 2352258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology, clinical staging, and presentation of renal cell carcinoma.
    Decastro GJ; McKiernan JM
    Urol Clin North Am; 2008 Nov; 35(4):581-92; vi. PubMed ID: 18992612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma.
    Schouten LJ; van Dijk BA; Oosterwijk E; van Engeland M; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Kester A; de Vogel S; Schalken JA; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3543-50. PubMed ID: 19064569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference?
    Brauch H; Weirich G; Klein B; Rabstein S; Bolt HM; Brüning T
    Toxicol Lett; 2004 Jun; 151(1):301-10. PubMed ID: 15177666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BMI and the risk of renal cell carcinoma.
    McGuire BB; Fitzpatrick JM
    Curr Opin Urol; 2011 Sep; 21(5):356-61. PubMed ID: 21730854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity, hypertension, and the risk of kidney cancer in men.
    Chow WH; Gridley G; Fraumeni JF; Järvholm B
    N Engl J Med; 2000 Nov; 343(18):1305-11. PubMed ID: 11058675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.